Schofield D E, Yunis E J, Geyer J R, Albright A L, Berger M S, Taylor S R
Department of Pathology, Children's Hospital, Boston, MA 02115.
Cancer. 1992 Mar 1;69(5):1307-14. doi: 10.1002/cncr.2820690539.
The authors reviewed clinical features, surgical extent of resection, histologic parameters, and DNA content in 55 children with medulloblastomas and found that complete or near total resection, absence of tumor dissemination, tumor DNA aneuploidy, and low proliferative index correlated with a favorable clinical outcome. A scoring system was developed based upon these features to identify patients who, in the future, may benefit from more aggressive or novel therapeutic regimens. Patient age and sex and adjuvant chemotherapy did not significantly correlate with long-term survival. The data also suggest that tumors that have been designated as cerebellar neuroblastomas may be a distinct group of posterior fossa tumors, which may have a better prognosis.
作者回顾了55例髓母细胞瘤患儿的临床特征、手术切除范围、组织学参数和DNA含量,发现完整或接近完全切除、无肿瘤播散、肿瘤DNA非整倍体以及低增殖指数与良好的临床结果相关。基于这些特征开发了一种评分系统,以识别未来可能从更积极或新颖的治疗方案中获益的患者。患者年龄、性别和辅助化疗与长期生存无显著相关性。数据还表明,被指定为小脑神经母细胞瘤的肿瘤可能是一组独特的后颅窝肿瘤,其预后可能更好。